Skip to content
1887

Graphical Abstract

Graphical abstract

Abstract

The human lower gastrointestinal tract microbiome is complex, dynamic and prone to disruption occurring during critical illness.

. The characteristics of lower gastrointestinal tract microbiome disruption and its association with clinical outcomes in patients with prolonged intensive care stay remain uncertain.

. To systematically review studies describing lower gastrointestinal tract molecular sequencing in patients with prolonged intensive care stay and explore associations with clinical outcomes.

. This systematic review was prospectively registered and follows the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. OVID MEDLINE, EMBASE and The Cochrane Central Register of Controlled Trials databases were searched for eligible studies describing adults and/or children who underwent molecular sequencing of stool or rectal samples taken on or after 10 days of intensive care.

. There were 13 studies with 177 patients included. The overall certainty of evidence was low, and no studies reported mortality. Reduced alpha diversity was observed in nine out of nine studies but was not associated with clinical outcomes in four out of four studies. Longitudinal alpha diversity decreased in five out of six studies, and inter-individual beta diversity increased in five out of five studies. After approximately one week of intensive care unit admission, rapid fluctuations in dominant taxa stabilized with trajectories of either recovery or deterioration in five studies. Pathogenic enrichment and commensal depletion were reported in all 13 studies and associated with clinical outcomes in two studies.

. Lower gastrointestinal tract microbiome disruption is highly prevalent and has consistent characteristics in patients with prolonged intensive care stay. Amongst reported metrics, only relative taxon abundance was associated with clinical outcomes.

Funding
This study was supported by the:
  • National Health and Medical Research Council (Award 2017081)
    • Principal Award Recipient: EdwardLitton
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001888
2024-10-09
2025-12-06

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/jmm/73/10/jmm001888.html?itemId=/content/journal/jmm/10.1099/jmm.0.001888&mimeType=html&fmt=ahah

References

  1. Petersen C, Round JL. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol 2014; 16:1024–1033 [View Article] [PubMed]
    [Google Scholar]
  2. Evans T, Ali U, Anderton R, Raby E, Manning L et al. Lower gut dysbiosis and mortality in acute critical illness: a systematic review and meta-analysis. Intensive Care Med Exp 2023; 11:6 [View Article] [PubMed]
    [Google Scholar]
  3. Iwashyna TJ, Hodgson CL, Pilcher D, Bailey M, Bellomo R. Persistent critical illness characterised by Australian and New Zealand ICU clinicians. Crit Care Resusc 2015; 17:153–158 [PubMed]
    [Google Scholar]
  4. Darvall JN, Boonstra T, Norman J, Murphy D, Bailey M et al. Persistent critical illness: baseline characteristics, intensive care course, and cause of death. Crit Care Resusc 2019; 21:110–118 [PubMed]
    [Google Scholar]
  5. Bagshaw SM, Stelfox HT, Iwashyna TJ, Bellomo R, Zuege D et al. Timing of onset of persistent critical illness: a multi-centre retrospective cohort study. Intensive Care Med 2018; 44:2134–2144 [View Article] [PubMed]
    [Google Scholar]
  6. Harrison DA, Creagh-Brown BC, Rowan KM. Timing and burden of persistent critical illnessin UK intensive care units: an observational cohort study. J Intensive Care Soc 2023; 24:139–146 [View Article] [PubMed]
    [Google Scholar]
  7. Kerckhoffs MC, Brinkman S, de Keizer N, Soliman IW, de Lange DW et al. The performance of acute versus antecedent patient characteristics for 1-year mortality prediction during intensive care unit admission: a national cohort study. Crit Care 2020; 24:330 [View Article] [PubMed]
    [Google Scholar]
  8. Wozniak H, Beckmann TS, Fröhlich L, Soccorsi T, Le Terrier C et al. The central and biodynamic role of gut microbiota in critically ill patients. Crit Care 2022; 26:250 [View Article] [PubMed]
    [Google Scholar]
  9. Matthew JP, Joanne EM, Patrick MB, Isabelle B, Tammy CH et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372:71 [View Article]
    [Google Scholar]
  10. Kim SY, Park JE, Lee YJ, Seo H-J, Sheen S-S et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol 2013; 66:408–414 [View Article] [PubMed]
    [Google Scholar]
  11. Zaborin A, Smith D, Garfield K, Quensen J, Shakhsheer B et al. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness. mBio 2014; 5:e01361–14 [View Article] [PubMed]
    [Google Scholar]
  12. Rogers MB, Firek B, Shi M, Yeh A, Brower-Sinning R et al. Disruption of the microbiota across multiple body sites in critically ill children. Microbiome 2016; 4:66 [View Article] [PubMed]
    [Google Scholar]
  13. Wurm P, Spindelboeck W, Krause R, Plank J, Fuchs G et al. Antibiotic-associated apoptotic enterocolitis in the absence of a defined pathogen: the role of intestinal microbiota depletion. Crit Care Med 2017; 45:e600–e606 [View Article] [PubMed]
    [Google Scholar]
  14. Xu R, Tan C, Zhu J, Zeng X, Gao X et al. Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death. Crit Care 2019; 23:195 [View Article] [PubMed]
    [Google Scholar]
  15. Ravi A, Halstead FD, Bamford A, Casey A, Thomson NM et al. Loss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients. Microb Genom 2019; 5:e000293 [View Article] [PubMed]
    [Google Scholar]
  16. Chernevskaya E, Beloborodova N, Klimenko N, Pautova A, Shilkin D et al. Serum and fecal profiles of aromatic microbial metabolites reflect gut microbiota disruption in critically ill patients: a prospective observational pilot study. Crit Care 2020; 24:312 [View Article] [PubMed]
    [Google Scholar]
  17. Lima KM, Davis RR, Liu SY, Greenhalgh DG, Tran NK. Longitudinal profiling of the burn patient cutaneous and gastrointestinal microbiota: a pilot study. Sci Rep 2021; 11:10667 [View Article] [PubMed]
    [Google Scholar]
  18. Kean IRL, Wagner J, Wijeyesekera A, De Goffau M, Thurston S et al. Profiling gut microbiota and bile acid metabolism in critically ill children. Sci Rep 2022; 12:10432 [View Article] [PubMed]
    [Google Scholar]
  19. Ojima M, Shimizu K, Motooka D, Ishihara T, Nakamura S et al. Gut dysbiosis associated with antibiotics and disease severity and its relation to mortality in critically Ill patients. Dig Dis Sci 2022; 67:2420–2432 [View Article] [PubMed]
    [Google Scholar]
  20. Sun Z, Zhu QL, Shen Y, Yan T, Zhou X. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations. Kaohsiung J Med Sci 2020; 36:107–113 [View Article] [PubMed]
    [Google Scholar]
  21. Chernevskaya E, Klimenko N, Pautova A, Buyakova I, Tyakht A et al. Host-microbiome interactions mediated by phenolic metabolites in chronically critically Ill patients. Metabolites 2021; 11:122 [View Article] [PubMed]
    [Google Scholar]
  22. Ivanova V, Chernevskaya E, Vasiluev P, Ivanov A, Tolstoganov I et al. Hi-C metagenomics in the ICU: exploring clinically relevant features of gut microbiome in chronically critically Ill patients. Front Microbiol 2022 [View Article]
    [Google Scholar]
  23. Fontaine C, Armand-Lefèvre L, Magnan M, Nazimoudine A, Timsit J-F et al. Relationship between the composition of the intestinal microbiota and the tracheal and intestinal colonization by opportunistic pathogens in intensive care patients. PLoS One 2020; 15:e0237260 [View Article] [PubMed]
    [Google Scholar]
  24. Brusselaers N, Vogelaers D, Blot S. The rising problem of antimicrobial resistance in the intensive care unit. Ann Intensive Care 2011; 1:47 [View Article] [PubMed]
    [Google Scholar]
  25. Zilahi G, McMahon MA, Povoa P, Martin-Loeches I. Duration of antibiotic therapy in the intensive care unit. J Thorac Dis 2016; 8:3774–3780 [View Article] [PubMed]
    [Google Scholar]
  26. Mittal R, Coopersmith CM. Redefining the gut as the motor of critical illness. Trends Mol Med 2014; 20:214–223 [View Article] [PubMed]
    [Google Scholar]
  27. Eichelberger KR, Paul S, Peters BM, Cassat JE. Candida-bacterial cross-kingdom interactions. Trends Microbiol 2023; 31:1287–1299 [View Article] [PubMed]
    [Google Scholar]
  28. Mirzayi C, Renson A, Furlanello C, Sansone S-A, Zohra F et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nat Med 2021; 27:1885–1892 [View Article]
    [Google Scholar]
  29. Irwin AD, Coin LJM, Harris PNA, Cotta MO, Bauer MJ et al. Optimising treatment outcomes for children and adults through rapid genome sequencing of Sepsis pathogens. A study protocol for A prospective, Multi-Centre Trial (DIRECT) [Methods]. Front Cell Infect Microbiol 2021; 11:667680 [View Article]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001888
Loading
/content/journal/jmm/10.1099/jmm.0.001888
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error